| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| CAGR | 10.21% |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Cancer Vaccines Market Analysis by Mordor Intelligence
The Europe Cancer Vaccines Market is expected to register a CAGR of 10.21% during the forecast period.
The increasing incidence of cancer has been the major factor for the growth of the European cancer vaccine market. Cancer vaccines play a vital role in the maintenance of the immune system, as they are biological response modifiers. Moreover, healthcare physicians are looking for alternate therapies, due to the huge burden of cancer cases and the side effects of the present therapies. Hence, the market for cancer vaccines is expected to grow at a high rate, during the forecast period.
According to the Global Cancer Observatory, the number of new incident cancer cases for the year 2018 was 4.2 million and the deaths exceeded 1.94 million in Europe. Thus, the growing incidence and prevalence of cancer are likely to drive the growth of the cancer therapeutics market in Europe during the forecast period.
Europe Cancer Vaccines Market Trends and Insights
Preventive Vaccines are Expected to a Hold Significant Market Share in the Treatment Method
Preventive vaccines or prophylactic vaccines are the vaccines intended to prevent cancer in healthy people. These vaccines work by preventing infectious agents that cause or contribute to the development of cancer. The European Medical Authority has approved Gardasil, Gardasil 9, and Cervarix vaccines to protect women from cervical cancer and other HPV-related cancers and pre-cancerous conditions.
According to GLOBOCAN 2018, report, the number of incident cervical cancer cases in Europe were 61,072 cases and the total number of cancer cases was 56,9847. Therefore as cancer cases are increasing in Europe, the demand for cancer vaccines is expected to increase due to the rising incidence of cancer in the region. Therefore all these factors has helped in the overall market growth.
Understand The Key Trends Shaping This Market
Download PDF
Competitive Landscape
The Europe Cancer Vaccines Market is s highly competitive and consists of a few major players. Companies, like Amgen Inc., OSE Immunotherapeutics, Merck & Co. Inc., Bristol-Myers Squibb, among others, hold substantial shares in the Europe cancer vaccines market.
Europe Cancer Vaccines Industry Leaders
-
Merck & Co. Inc.
-
Bristol-Myers Squibb
-
OSE Immunotherapeutics
-
Amgen Inc.
-
GlaxoSmithKline PLC
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
Europe Cancer Vaccines Market Report Scope
As per the scope of the report, cancer vaccines are defined as the vaccines developed to prevent or treat existing cancers, by strengthening the body's natural immune response system against cancer. These cancer vaccines belong to a class of substances, known as biological response modifiers. These modifiers work by stimulating or restoring the immune system's ability to fight against diseases.
By Technology
| Recombinant Cancer Vaccines |
| Whole-cell Cancer Vaccines |
| Viral Vector and DNA Cancer Vaccines |
| Other Technologies |
By Treatment Method
| Preventive Vaccine |
| Therapeutic Vaccine |
By Application
| Prostate Cancer |
| Cervical Cancer |
| Other Applications |
Geography
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
| By Technology | Recombinant Cancer Vaccines | |
| Whole-cell Cancer Vaccines | ||
| Viral Vector and DNA Cancer Vaccines | ||
| Other Technologies | ||
| By Treatment Method | Preventive Vaccine | |
| Therapeutic Vaccine | ||
| By Application | Prostate Cancer | |
| Cervical Cancer | ||
| Other Applications | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
What is the current Europe Cancer Vaccines Market size?
The Europe Cancer Vaccines Market is projected to register a CAGR of 10.21% during the forecast period (2025-2030)
Who are the key players in Europe Cancer Vaccines Market?
Merck & Co. Inc., Bristol-Myers Squibb, OSE Immunotherapeutics, Amgen Inc. and GlaxoSmithKline PLC are the major companies operating in the Europe Cancer Vaccines Market.
What years does this Europe Cancer Vaccines Market cover?
The report covers the Europe Cancer Vaccines Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Cancer Vaccines Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Europe Cancer Vaccines Market Report
Statistics for the 2025 Europe Cancer Vaccines market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Cancer Vaccines analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
